NCT00298064

Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of New Mexico · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

The Tissue Repository will search for cases, pull slides, Paraffin-embedded tissue (PET) blocks.

Detailed description

This study is done to gather preliminary data for determining the best way to test EGFR expression in patients with cervical cancer who will receive treatment with EGFR inhibitors in the future. This study is designed to obtain preliminary data of genomic and phenotypic alterations of the EGFR pathway in high grade cervical intraepithelial lesions (HG-SIL) and invasive cervical cancers (CC) to be used later for therapeutic guidance and to evaluate genomic (over-expression, amplification, point mutations, etc.) and phenotypic alterations of other transduction pathways interacting with the EGFR pathway.

Conditions

• Cervical Cancer
• Cervix

Interventions

Type	Name	Description
GENETIC	Tissue Repository

Timeline

• Start date: 2005-12-01
• Primary completion: 2005-12-01
• Completion: 2005-12-01
• First posted: 2006-03-01
• Last updated: 2023-07-05

Locations

1 site across 1 country: United States